Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

DSE:IBP Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jul 1, 2022	Jul 1, 2021
Market Capitalization	1,371	1,522	1,546	1,975	2,036	2,186
Market Cap Growth	40.48%	-1.50%	-21.77%	-2.97%	-6.88%	-1.96%
Enterprise Value	1,387	1,544	1,570	2,047	2,079	2,262
Last Close Price	11.80	13.08	13.27	16.96	17.75	18.68
PE Ratio	-	-	-	234.98	80.87	16.23
PS Ratio	7.45	8.27	8.75	5.28	4.20	2.80
PB Ratio	0.94	1.05	0.98	1.22	1.25	1.35
P/TBV Ratio	0.94	1.05	0.98	1.22	1.25	1.35
P/FCF Ratio	23.69	26.30	65.38	46.03	42.77	-
P/OCF Ratio	23.46	26.05	45.77	27.08	23.33	14.48
EV/Sales Ratio	7.53	8.38	8.89	5.47	4.29	2.89
EV/EBITDA Ratio	-	350.91	328.22	30.53	27.74	10.81
EV/EBIT Ratio	-	-	-	71.35	58.07	13.05
EV/FCF Ratio	23.96	26.67	66.42	47.69	43.67	-
Debt / Equity Ratio	0.01	0.01	0.02	0.03	0.05	0.05
Debt / EBITDA Ratio	4.55	4.55	5.06	0.65	1.01	0.41
Debt / FCF Ratio	0.35	0.35	1.02	1.02	1.58	-
Asset Turnover	0.10	0.10	0.10	0.20	0.26	0.43
Inventory Turnover	1.23	1.23	0.92	1.55	1.76	2.39
Quick Ratio	1.71	1.71	2.12	1.88	1.61	1.65
Current Ratio	3.62	3.62	4.95	4.26	3.50	3.57
Return on Equity (ROE)	-2.43%	-2.43%	-2.56%	0.52%	1.55%	8.57%
Return on Assets (ROA)	-0.85%	-0.85%	-0.80%	0.95%	1.18%	5.95%
Return on Capital (ROIC)	-0.98%	-0.98%	-0.91%	1.06%	1.31%	6.71%
Return on Capital Employed (ROCE)	-1.50%	-1.50%	-1.40%	1.60%	2.10%	10.00%
Earnings Yield	-2.69%	-2.42%	-2.65%	0.43%	1.24%	6.16%
FCF Yield	4.22%	3.80%	1.53%	2.17%	2.34%	-2.26%
Dividend Yield	0.13%	0.11%	0.07%	-	0.56%	2.14%
Payout Ratio	-	-	-	123.72%	98.46%	19.97%
Buyback Yield / Dilution	-	-	-	-	-2.17%	-
Total Shareholder Return	0.13%	0.11%	0.07%	-	-1.61%	2.14%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.